Egyptian International Pharmaceutical Investments (CAI:PHAR) Total Debt per Share : E£64.42 (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Total Debt per Share?

E£64.42 (As of Mar. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Egyptian International Pharmaceutical Investments's Total Debt Per Share for the quarter that ended in Mar. 2025 was E£64.42.

Egyptian International Pharmaceutical Investments Total Debt per Share Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Total Debt per Share Chart

Egyptian International Pharmaceutical Investments Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Debt per Share

Get a 7-Day Free Trial

13.56

22.08

32.81

61.85

Egyptian International Pharmaceutical Investments Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Debt per Share	Get a 7-Day Free Trial															48.63	55.20	59.28	61.85	64.42

Egyptian International Pharmaceutical Investments Total Debt per Share Calculation

Egyptian International Pharmaceutical Investments's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(4,793	+	4,407)	/	149
	=	61.85

Egyptian International Pharmaceutical Investments's Total Debt Per Share for the quarter that ended in Mar. 2025 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(4,627	+	4,956)	/	149
	=	64.42

Egyptian International Pharmaceutical Investments Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Egyptian International Pharmaceutical Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, P.O. Box 149 10th, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.